Company intelligence / Profile preview

BModesto

Lelystad, Flevoland, Netherlands

Ownership: Private
Employees: ~88
Development stage: Other

Overview

BModesto is an independent international pharmaceutical wholesaler specializing in parallel import of medicines in the Netherlands and the EU. The company does not develop novel therapeutics but specializes in sourcing, importing, and distributing generic medicines, OTC products, and medical devices. It plays a key role in improving access to affordable medicines across Europe, emphasizing high quality, reliable supply, and competitive pricing. BModesto is part of the Irish Uniphar Group, following acquisition in 2022.

Therapeutic areas: Cardiovascular
Modalities: Small moleculeMedical Devices
Industry: Non-Academic Healthcare

Beyond the preview

Go deeper on BModesto.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BModesto.

Explore the full profile